Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

5.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Clinical Trials01:16

Clinical Trials

10.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Quality Control01:05

Quality Control

2.6K
Quality control is one of the three cyclical quality assurance activities that help keep a system under statistical control. Typical quality control activities include creating quality control charts, conducting proficiency testing, and documenting and archiving results.
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
2.6K
GIS Software, Hardware, and Sources of GIS Data01:23

GIS Software, Hardware, and Sources of GIS Data

793
A Geographic Information System (GIS) combines specialized software and hardware to effectively manage, analyze, and present spatial and related data. GIS software includes critical functionalities such as a user interface for easy navigation, database management tools for handling spatial and attribute data, and data retrieval features for efficient access. Analytical tools transform raw data into insights, while display functions produce maps and reports in various formats for effective...
793

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Food Safety Implementation and Associated Challenges: Insights from Cambodia's Pangasius Fish and Chicken Farms.

Veterinary sciences·2026
Same author

Insights Informing Strategies for Optimizing the Collection of Clinical Trial Data.

Therapeutic innovation & regulatory science·2025
Same author

Evaluation of Mycoplasma genitalium positivity and co-infection with Chlamydia trachomatis and/or Neisseria gonorrhoeae at various care sites across the United States.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2025
Same author

Measuring the IMPACT: Pilot Validation of a Novel Patient-Reported Outcome Measure for Craniomaxillofacial Trauma.

Facial plastic surgery & aesthetic medicine·2025
Same author

Partial D variant with demonstrated risk of D alloimmunization in the Australian Indigenous population.

Vox sanguinis·2025
Same author

An international multi-site study to evaluate the analytical and clinical performance of the quantitative high-throughput Alinity m CMV assay.

Microbiology spectrum·2025

Related Experiment Video

Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials.

Nicole Sheetz1, Brett Wilson2, Joanne Benedict3

  • 11 Clinical Development Innovation, Eli Lilly and Company, Indianapolis, IN, USA.

Therapeutic Innovation & Regulatory Science
|September 20, 2018
PubMed
Summary

Risk-based monitoring enhances clinical trial quality and safety by focusing on critical study aspects, moving beyond traditional source data verification (SDV). This approach proves more effective than generalized SDV.

Keywords:
data integrityquality controlrisk-based monitoringsource data reviewsource data verification

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K
Continuous-Wave Propagation Channel-Sounding Measurement System - Testing, Verification, and Measurements
09:36

Continuous-Wave Propagation Channel-Sounding Measurement System - Testing, Verification, and Measurements

Published on: June 25, 2021

3.5K

Related Experiment Videos

Last Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K
Continuous-Wave Propagation Channel-Sounding Measurement System - Testing, Verification, and Measurements
09:36

Continuous-Wave Propagation Channel-Sounding Measurement System - Testing, Verification, and Measurements

Published on: June 25, 2021

3.5K

Area of Science:

  • Clinical trial operations
  • Drug development quality assurance
  • Regulatory compliance in research

Background:

  • Traditional clinical trial monitoring heavily relies on source data verification (SDV).
  • Emerging evidence suggests risk-based monitoring (RBM) may yield superior outcomes.
  • TransCelerate BioPharma Inc. developed a novel RBM methodology.

Purpose of the Study:

  • To assess the value of source data verification (SDV) in clinical trial monitoring.
  • To evaluate the effectiveness of TransCelerate's risk-based monitoring (RBM) approach.
  • To compare RBM strategies against conventional SDV-driven models.

Main Methods:

  • Literature review on SDV's role in clinical trial monitoring.
  • Retrospective analysis of data from multiple clinical trials.
  • Assessment of internal audit findings from TransCelerate member companies.

Main Results:

  • Generalized SDV demonstrates limited value as a primary quality control measure.
  • Risk-based monitoring activities provide significant value in ensuring data quality and subject safety.
  • RBM, incorporating risk assessment and adaptive monitoring, is more effective than SDV-centric models.

Conclusions:

  • The study supports the hypothesis that generalized SDV has limited value.
  • Risk-based monitoring activities are more effective in ensuring clinical trial quality and subject safety.
  • Transitioning from SDV to RBM is recommended for improved clinical trial oversight.